Search

Your search keyword '"Targher, G"' showing total 1,117 results

Search Constraints

Start Over You searched for: Author "Targher, G" Remove constraint Author: "Targher, G"
1,117 results on '"Targher, G"'

Search Results

13. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

16. A global research priority agenda to advance public health responses to fatty liver disease

24. Global multi-stakeholder endorsement of the MAFLD definition

25. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

26. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

27. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

28. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16

29. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' [Dig Liver Dis 54 (2022) 170-182]

30. Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes

31. SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: A five-year follow-up study

37. Global multi-stakeholder endorsement of the MAFLD definition

38. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

39. Global multi-stakeholder endorsement of the MAFLD definition

40. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Catalog

Books, media, physical & digital resources